POET Technologies: A $400M Capital Raise, a 22% Stock Crash, and a Flood of Class Actions — All in One Week

POET raised $400M in dilutive offering, shares fell 22%, CFO resigned, and lawsuits filed. Revenue negligible but $500M Lumilens deal offers future growth.

The week of May 15, 2026, may go down as one of the most eventful in POET Technologies' short public history. In a matter of days, the photonics chipmaker closed a $400 million capital raise, watched its shares plunge by over a fifth, lost its chief financial officer of a decade, and saw multiple law firms file class-action lawsuits. The stock finished Friday at $15.97, down 22.36% — a sharp reversal after a 46% rally since May 8.

A Premium Placement With a Dilution Catch

The registered direct offering, expected to close on Monday, May 18, involves the issuance of roughly 19.05 million units at $21.00 apiece. Each unit consists of one common share and one warrant exercisable at $26.15 for three years. For existing shareholders, the math is straightforward: the company gains a war chest for scaling operations, but the influx of new shares and warrants creates a clear dilution trade-off.

POET plans to deploy the proceeds toward expanding manufacturing infrastructure, potential acquisitions, research and development, and the buildout of its light-source product line. The capital is also a crucial buffer: the company’s operating cash burn was $8.8 million in the first quarter, roughly flat year-over-year, suggesting management is keeping costs in check even as it scales.

Small Revenue Base, Expanding Losses

First-quarter results illustrate the chasm between ambition and execution. Revenue came in at $503,389, a threefold jump from $166,760 a year earlier but still negligible for a business with a market capitalization around $3.14 billion. The net loss widened to $12.3 million, or $0.08 per share, swinging from a profit of $6.3 million in the year-ago period. Selling, general, and administrative expenses surged to $12.5 million, pushing the operating loss to $17.9 million.

On the balance sheet, equity ballooned to $448.6 million from $183.8 million at the end of 2025, thanks mostly to the financing round. Yet the company’s trailing twelve-month revenue of roughly $1.1 million translates into a price-to-sales ratio north of 1,200 — a number that leaves no room for execution missteps.

A $500 Million Customer Bet — and a Cancellation

The most tangible growth driver is a supply agreement with Lumilens, covering POET’s EOI platform for optical AI networks. The initial purchase order is worth $50 million, with a framework that could reach cumulative purchases exceeding $500 million over five years. Engineering samples are slated for late 2026, with production ramp linked to hyperscaler projects in 2027.

POET is also working with LITEON and Lessengers on a 1.6T transceiver module, with engineering samples expected by the end of 2026 and production in 2027. But these positive developments are overshadowed by the abrupt cancellation of all orders from Celestial AI, now part of Marvell. Marvell cited alleged breaches of confidentiality obligations — the same issue that plaintiffs’ lawyers are now using as a centerpiece in their class-action complaints.

Lawsuits, Tax Status, and a CFO’s Exit

On Sunday, May 17, multiple law firms filed class actions against POET on behalf of investors who bought shares between April 1 and April 27. The complaints accuse the company of making false or misleading statements and omitting material information, particularly regarding its possible classification as a Passive Foreign Investment Company (PFIC) under U.S. tax law — a status that could carry adverse tax consequences for American shareholders. The lead plaintiff deadline is set for June 29, 2026.

The lawsuits also target CFO Thomas Mika, who has served in the role for ten years. The claims allege that Mika disclosed sensitive business agreements in a public interview, violating confidentiality and jeopardizing commercial relationships — a charge plaintiffs directly link to the Marvell/Celestial AI order cancellations. Mika has since informed the board of his desire to step down, and a search for his successor is underway.

The timing of the CFO departure is particularly sensitive. POET is approaching critical production milestones: light-source manufacturing is expected to begin in Malaysia during the second quarter, followed by 800G optical modules in the third quarter. Investors are watching whether the leadership vacuum will slow those efforts.

A Redomestication Gambit

To address the PFIC concerns, POET’s board has approved a plan to relocate the company’s corporate seat and convert it into a U.S. entity. A shareholder vote on the proposal is tentatively scheduled for the annual general meeting on June 26, 2026. In the interim, the company says it will provide U.S. shareholders with information to make a QEF election for fiscal 2025, which could mitigate some tax disadvantages.

For now, POET Technologies finds itself in a precarious balance: it has ample cash, a marquee customer contract, and a strategic niche in AI optics. But it also faces legal overhang, a management transition, and a valuation that demands near-perfect execution. The next few months will determine whether the opportunities outweigh the risks — or whether the storm proves too strong for the stock to weather.